Patients taking semaglutide showed considerable improvement compared to those on placebo, potentially positioning semaglutide as a promising option for MASH
Additionally, in EPP, where patients experience sensitivity to visible light due to the accumulation of the photosensitizer protoporphyrin IX, melanotan 1 has shown promise in increasing skin melanin density, leading to increased tolerance to photoprovocation and reduced skin pain
Combining four bioactive peptides is a pharmacological decision with real consequences for dosing, for stability, for interactions, and for safety and there is no published work establishing that this particular combination is additive, synergistic, redundant, or even mutually compatible in solution
It can also reduce the likelihood of brittle bones and osteoporosis
Heres the protocol we recommend: Unopened Vials: Store them at controlled room temperature, typically between 20C to 25C (68F to 77F)